Healthcare -
Biotechnology - NASDAQ - US
$ 6.345
4.75 %
$ 513 M
Market Cap
-3.06
P/E
KURA - STOCK-BASED COMPENSATION
Stock-based Compensation KURA - Kura Oncology, Inc.
33.9 M
LAST VALUE
13.49%
2 YEAR CAGR
29.22%
5 YEAR CAGR
193.65%
10 YEAR CAGR